Home / Import refusals / 1FX-1355997-5/10001/1

FDA Import Refusal 1FX-1355997-5/10001/1 — Hospira, Inc.

Hospira, Inc. — FEI 1925262

The FDA refused shipment 1FX-1355997-5/10001/1 from Hospira, Inc. (United States) on April 14, 2026. The refused product falls under Drugs and Biologics — MECASERMIN RECOMBINANT. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
April 14, 2026
Country
United States
Product Category
Drugs and Biologics
Product Code
58HAY01 MECASERMIN RECOMBINANT
Charges
75

Recent inspections

  • 1255699 (VAI Fri Jan 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229140 (NAI Wed Mar 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1115467 (VAI Fri Jan 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1064827 (OAI Wed Aug 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1031233 (VAI Fri Oct 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • 9SN-0007009-6/81/1 (Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 9SN-0007009-6/21/1 (Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 9SN-0007009-6/71/1 (Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 8JB-0093850-4/11/47 (Wed Mar 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 8JB-0093850-4/11/15 (Wed Mar 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources